Loading...
XJPX
4208
Market cap2.05bUSD
Oct 09, Last price  
3,358.00JPY
1D
0.57%
1Q
6.70%
Jan 2017
37.06%
Name

UBE Corp

Chart & performance

D1W1MN
XJPX:4208 chart
P/E
13.67
P/S
0.71
EPS
245.74
Div yield, %
3.29%
Shrs. gr., 5y
-0.86%
Rev. gr., 5y
-5.51%
Revenues
462.34b
-5.02%
655,608,000,000704,284,000,000684,703,000,000549,556,000,000616,062,000,000638,653,000,000626,022,000,000650,510,000,000641,759,000,000641,750,000,000616,563,000,000695,574,000,000730,157,000,000667,892,000,000613,889,000,000655,265,000,000494,738,000,000468,237,000,000486,802,000,000462,343,000,000
Net income
23.87b
P
22,013,000,00024,031,000,00011,664,000,0008,217,000,00017,267,000,00022,969,000,0008,265,000,00012,623,000,00014,649,000,00019,111,000,00024,185,000,00031,680,000,00032,499,000,00022,976,000,00022,936,000,00024,500,000,000-7,034,000,00028,981,000,000-4,816,000,00023,872,000,000
CFO
59.98b
+67.38%
54,385,000,00058,814,000,00045,531,000,00060,107,000,00067,081,000,00040,630,000,00046,126,000,00037,060,000,00062,194,000,00068,628,000,00053,418,000,00073,386,000,00050,462,000,00068,489,000,00066,054,000,00032,711,000,00018,127,000,00052,960,000,00035,837,000,00059,984,000,000
Dividend
Mar 30, 202780 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1897 and headquartered in Tokyo, Japan, UBE Corporation, formerly known as Ube Industries, Ltd., is a globally diversified enterprise with core operations spanning chemicals, construction materials, and machinery. The company maintains a substantial international footprint, serving markets across Japan, North America, Europe, Africa, the Middle East, Thailand, India, Latin America, and other global regions. UBE's extensive chemicals division provides a wide range of products including synthetic rubber, engineering plastics, polyimide, polyethylene, caprolactam, nylon, plastic films, polypropylene molded products, fibers, fiber-reinforced plastics, industrial chemicals, liquefied gases, ammonium sulfate, battery components, separation membranes, fine chemicals, ceramics, high-purity chemicals, semiconductor gas products, and materials for polyurethane resins. Additionally, the company offers specialized chemical services such as contract manufacturing for active pharmaceutical ingredients (APIs) and intermediates, supplies aromatic SF5 compounds, markets FLUOLEAD (a novel nucleophilic fluorinating agent), and supports drug discovery and pipeline development initiatives. Within the construction materials segment, UBE supplies essential products like cement, ready-mixed concrete, soil stabilizing cement, general building materials, limestone, calcia, magnesia, and other specialty inorganic compounds. This division also actively engages in resource recycling and the distribution of coal. The machinery segment focuses on the production and supply of die-casting and injection molding machines, extrusion presses, UBE vertical mills, kilns, furnaces, dryers, water screening equipment, storage and transportation systems, bridges, steel structures, along with steel billets, cast iron, and various other steel products. Beyond these core areas, UBE Corporation is also involved in the generation and supply of electric power.

Key people

Masato Izumihara
Chairman of the Board · since 2025
Ryo Kawamura
Chief Compliance Officer, Chief Risk Officer, Executive Officer, Director · since 2025
Hisaaki Yokoo
Senior Managing Executive Officer, Director of Elastomer Business, President of Subsidiary · since 2025
Yoichi Funayama
Managing Executive Officer, Director of Medicine Business · since 2023
Hirofumi Nonaka
Managing Executive Officer, Director of Performance Polymers & Chemicals Business · since 2025
Shinya Takahashi
Managing Executive Officer, Director of Functional Product Business · since 2025
Futoshi Takase
Managing Executive Officer, Manager of Ube Business Office · since 2024
Seijiro Kamezawa
Executive Officer, Director of High Performance Urethane Business, Director of Planning and Administration, Director of Urethane Systems Sales · since 2025
Mitsuru Haramoto
Executive Officer, Assistant Manager of Ube Business Office, Manager of Ube Chemical Plant · since 2025
Kenji Hoshino
Executive Officer · since 2024
Jose Iglesias
Executive Officer · since 2024
Shino Nakada
Executive Officer · since 2026
Takaaki Nishimori
Executive Officer, Deputy Director of Business in Functional Products Business Unit · since 2025
Koji Sagaoka
Executive Officer, President & CEO of Subsidiary · since 2025
Kazuhito Soga
Executive Officer, Director of Pharmaceutical Business · since 2026
Anusara Suthikulavet
Executive Officer, President & CEO of Subsidiary · since 2025
Yoshihiro Ushigoe
Executive Officer, Director of Business Strategy · since 2026
Yoichi Yoshida
Executive Officer, Chief Director of Research & Development · since 2024
Masayuki Fujii
Director · since 2023
Hirotaka Ishikawa
Managing Executive Officer, Chief Financial Officer, Representative Director · since 2025
IPO date
May 30, 1949
Employees
8,106
Domiciled in
JP
Incorporated in
JP
Headquarters & legal address
大字小串1978番地の96
宇部市, 35 755-8633
JP
Previous name
Ube Industries, Ltd.
Other language
Ube Industries, Ltd.

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT